340B claims data requirements put hospital discounts under stress
2 Articles
2 Articles
Provider Law Firm Urges HHS IG Investigation into Lilly’s 340B Data Demands
A law firm representing 340B providers urged federal regulators Wednesday to investigate Eli Lilly’s new 340B in-house pharmacy claims data [...] The post Provider Law Firm Urges HHS IG Investigation into Lilly’s 340B Data Demands appeared first on 340B Report.
340B claims data requirements put hospital discounts under stress
Provider advocates criticized Eli Lilly for ramping up pressure on hospitals to comply with a new policy regarding claims submission in the 340B Drug Pricing Program. The drug manufacturer said holdout hospitals will lose 340B discounts on all Lilly products unless the hospitals quickly comply with a mandate issued earlier this year to submit claims data for in-house pharmacy claims. A notice to that effect was sent to the Health Resources and S…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
